Bulletin
Investor Alert

Coronavirus Update Archives | Email alerts

Aug. 26, 2021, 9:59 a.m. EDT

U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)
  • X
    CVS Health Corp. (CVS)

or Cancel Already have a watchlist? Log In

Jaimy Lee

The number of COVID-19 hospitalizations in the U.S. has been slowly ticking up, and new data shows that 100,000 people are currently hospitalized with COVID-19, a figure that is on track with hospitalizations over the winter.

The rapid spread of the delta variant, combined with the rollback of mitigation measures like social distancing and mask wearing, are thought to be behind the latest surge in cases, hospitalizations, and deaths in the U.S.

It’s the first time that this many people have been admitted to the hospital for COVID-19 treatment since January , according to the data compiled by The Washington Post. A separate report in Axios found that 77% of intensive-care unit beds in the U.S. are filled. And new COVID-19 admissions among children are at their highest levels over the last year, according to CNBC.

Most COVID-19 hospitalizations, however, are occurring in people between the ages of 18 and 49 years old (36.1%) and 50 and 64 years olds (28.3%) , according to Centers for Disease Control and Prevention data, as of Aug. 14.

Recent CDC data found that COVID-19 hospitalization rates were 17 times higher in unvaccinated Americans compared with vaccinated adults, and people who haven’t been vaccinated are 29 times more likely to end up hospitalized with a COVID-19 infection than people who are vaccinated, according to comments made Tuesday by CDC director Dr. Rochelle Walensky.

“These data remind us that if you are not yet vaccinated, you are among those highest at risk,” she said.

Here’s what the numbers say 

The seven-day moving average is 142,029 cases per day and 809 deaths per day in the U.S., as of Aug. 24, according to the latest CDC data .

About 171.7 million people in the U.S., or 51.7% of the total population (which includes those younger than 12, who are young for eligibility), are fully vaccinated, as of Aug. 25. Of those who qualify for vaccination, 202.2 million, or 71.3%, have received at least one shot, and 171.6 million, or 60.4%, are fully vaccinated. 

In total, the U.S. has reported 38.2 million cases and 632,272 deaths during the pandemic.

Here’s what to know from the week’s flurry of COVID-19 vaccine news 

1. BioNTech SE /zigman2/quotes/214419716/composite BNTX +2.43% and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.67% received “full” approval from the Food on Drug Administration for the mRNA shot they developed together. The vaccine is now called Comirnaty. The announcement set off a number of new vaccine mandates for workers at companies like CVS Health Corp. /zigman2/quotes/209664499/composite CVS +1.94% and Chevron Corp. /zigman2/quotes/205871374/composite CVX +1.28% and even a change in how much unvaccinated Delta Air Lines Inc. /zigman2/quotes/200327741/composite DAL -0.52% workers have to pay for their own health care costs .

2. The companies also initiated a n application to get a third “booster” dose of their vaccine approved by the FDA.

3. Moderna Inc. /zigman2/quotes/205619834/composite MRNA -0.28% announced it had submitted its mRNA shot for full approval .

4. Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.04% said that new results from a clinical study found that a second dose of its COVID-19 vaccine boosted antibody levels . The announcement, though short on clinical details, indicates that booster shots may be coming for recipients of the single-shot J&J vaccine. 

/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 269.25
+6.39 +2.43%
Volume: 1.90M
Oct. 20, 2021 3:59p
P/E Ratio
14.08
Dividend Yield
N/A
Market Cap
$63.75 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 42.80
+0.70 +1.67%
Volume: 18.98M
Oct. 20, 2021 3:59p
P/E Ratio
18.29
Dividend Yield
3.65%
Market Cap
$235.99 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/209664499/composite
US : U.S.: NYSE
$ 86.54
+1.65 +1.94%
Volume: 3.41M
Oct. 20, 2021 3:59p
P/E Ratio
15.88
Dividend Yield
2.31%
Market Cap
$112.02 billion
Rev. per Employee
$895,513
loading...
/zigman2/quotes/205871374/composite
US : U.S.: NYSE
$ 113.13
+1.43 +1.28%
Volume: 9.12M
Oct. 20, 2021 3:59p
P/E Ratio
60.67
Dividend Yield
4.74%
Market Cap
$216.02 billion
Rev. per Employee
$1.98M
loading...
/zigman2/quotes/200327741/composite
US : U.S.: NYSE
$ 40.24
-0.21 -0.52%
Volume: 13.40M
Oct. 20, 2021 3:59p
P/E Ratio
N/A
Dividend Yield
0.00%
Market Cap
$25.89 billion
Rev. per Employee
$231,014
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 332.69
-0.92 -0.28%
Volume: 4.39M
Oct. 20, 2021 3:59p
P/E Ratio
41.46
Dividend Yield
N/A
Market Cap
$134.66 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 163.81
-0.06 -0.04%
Volume: 4.47M
Oct. 20, 2021 3:59p
P/E Ratio
24.48
Dividend Yield
2.59%
Market Cap
$431.38 billion
Rev. per Employee
$613,918
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.